Global Asparaginase Market Size study, by Type (Escherichia Coli, Erwinia Chrysanthemi, Pegylated) by Application (Healthcare, Food Industry, Others) and Regional Forecasts 2019-2026

  • Report Id: BIZ 3066
  • Published Date: April, 2020
  • No of Pages: 200
  • Format: Electronic (PDF)
  • Publisher: Bizwit Research & Consulting LLP
  • Category:

Global Asparaginase Market is valued approximately at USD XXX million in 2018 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2019-2026. Asparaginase is an enzyme which catalzes the hydrolysis of l-asparagine to l-aspartic acid and ammonia. Asparaginase products are isolated from different types of bacteria, namely Escherichia coli and Erwinia chrysanthemi. They inhibit protein synthesis in tumor cells by depriving them of the amino acid asparagine. These are used widely in Healthcare industry and Food manufacturing industry as a medication. It is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. As Asparaginase was approved for medical use in the United States in 1978. It is also on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. Asparaginase is used in the food manufacturing to reduce the formation of acrylamide. Acrylamide is a carcinogen in the starch containing food products such as biscuits and snacks. Thus, the rapidly growing healthcare and food manufacturing industry increase the demand for Asparaginase during the forecast period. As the Food and drinks market in Europe contributed to be the largest manufacturing sector in 2017 with a turnover of USD 1222 billion. The same sector invested USD 3.12 billion in research & development in 2017 which shows a positive sign in the market growth. Further, the rising investments of the market players for the research and development and production of Asparaginase according to the regulatory specification due to the rise in demand further fuels the market growth. However, the side effects of Asparaginase on human body such as mild bone marrow suppression, pancreatitis, anticoagulant factor resulting in stroke and bleeding hinders the market growth.

The regional analysis of global Asparaginase market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the dominant pharmaceutical industry in the region which is the major industry which uses Asparaginase enzyme. Further rising cases of Leukemia in the region propel the market growth. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing population along with increasing disposable income coupled with growing food manufacturing industry would create lucrative growth prospects for the Asparaginase market across Asia-Pacific region.

Major market player included in this report are:
Jazz Pharmaceuticals Plc
Shire Plc
Medac GmbH
Kyowa Hakko Kirin Co., Ltd.
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
Exova SL Pharma Inc
United Biotech Pvt. Ltd.
Novus Biologicals
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Escherichia Coli
Erwinia Chrysanthemi
Pegylated
By Application:
Healthcare
Food Industry
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Asparaginase Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investor

Companies:

Jazz Pharmaceuticals Plc
Shire Plc
Medac GmbH
Kyowa Hakko Kirin Co., Ltd.
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
Exova SL Pharma Inc
United Biotech Pvt. Ltd.
Novus Biologicals

Countries:

U.S.
Canada
UK
Germany
France
China
India
Japan
Brazil
Mexico

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Asparaginase Market, by Region, 2017-2026 (USD Billion)
1.2.2. Asparaginase Market, by Type, 2017-2026 (USD Billion)
1.2.3. Asparaginase Market, by Application, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Asparaginase Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Asparaginase Market Dynamics
3.1. Asparaginase Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Asparaginase Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Asparaginase Market, by Type
5.1. Market Snapshot
5.2. Global Asparaginase Market by Type, Performance – Potential Analysis
5.3. Global Asparaginase Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Asparaginase Market, Sub Segment Analysis
5.4.1. Escherichia Coli
5.4.2. Erwinia Chrysanthemi
5.4.3. Pegylated
Chapter 6. Global Asparaginase Market, by Application
6.1. Market Snapshot
6.2. Global Asparaginase Market by Application, Performance – Potential Analysis
6.3. Global Asparaginase Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4. Asparaginase Market, Sub Segment Analysis
6.4.1. Healthcare
6.4.2. Food Industry
6.4.3. Others
Chapter 7. Global Asparaginase Market, Regional Analysis
7.1. Asparaginase Market, Regional Market Snapshot
7.2. North America Asparaginase Market
7.2.1. U.S. Asparaginase Market
7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
7.2.1.2. Application breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Asparaginase Market
7.3. Europe Asparaginase Market Snapshot
7.3.1. U.K. Asparaginase Market
7.3.2. Germany Asparaginase Market
7.3.3. Rest of Europe Asparaginase Market
7.4. Asia-Pacific Asparaginase Market Snapshot
7.4.1. China Asparaginase Market
7.4.2. India Asparaginase Market
7.4.3. Japan Asparaginase Market
7.4.4. Rest of Asia Pacific Asparaginase Market
7.5. Latin America Asparaginase Market Snapshot
7.5.1. Brazil Asparaginase Market
7.5.2. Mexico Asparaginase Market
7.6. Rest of The World Asparaginase Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Jazz Pharmaceuticals
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Shire
8.2.3. Medac GmbH
8.2.4. Kyowa Hakko Kirin Pvt. Ltd.
8.2.5. Qianhong Bio-pharma
8.2.6. Taj Pharmaceuticals
8.2.7. Mingxing Pharma
8.2.8. Exova SL Pharma Inc SL Pharma
8.2.9. United Biotech Pvt. Ltd Novus Biologicals
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ASPARAGINASE MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ASPARAGINASE MARKET
TABLE 3. GLOBAL ASPARAGINASE MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 9. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
FIG 1. GLOBAL ASPARAGINASE MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL ASPARAGINASE MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL ASPARAGINASE MARKET, KEY TRENDS 2018
FIG 5. GLOBAL ASPARAGINASE MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL ASPARAGINASE MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL ASPARAGINASE MARKET, PEST ANALYSIS
FIG 8. GLOBAL ASPARAGINASE MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL ASPARAGINASE MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL ASPARAGINASE MARKET, COMPANY MARKET SHARE ANALYSIS (2018)

Choose License Type

Single user
$4,950
Enterprise User
$6,250
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.